News
1d
InvestorsHub on MSNRocket Pharmaceuticals Shares Jump After FDA Grants Accelerated Review Status to Gene TherapyRocket Pharmaceuticals Inc. (NASDAQ:RCKT) surged 15% after receiving a key regulatory boost from the U.S. Food and Drug ...
Lawmakers on the Senate Budget, Appropriations and Finance Committee seemed keen on investing in the territory’s athletes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results